There is a growing consensus that drug discovery thrives in an open environment. Here, we describe how the malaria community has embraced four levels of open data – open science, open innovation, open access and open source – to catalyse the development of new medicines, and consider principles that could enable open data approaches to be applied to other disease areas.
All Keywords